Cash, cash equivalents and marketable securities were $352.4 million as of December 31, 2024, compared to $75.2 million as of December 31, 2023. Based on current operating plans, Metsera (MTSR) estimates its existing cash and cash equivalents of $352.4 at year end, together with the net proceeds from the IPO, will be sufficient to fund our projected operating expenses, working capital and capital expenditure needs into 2027.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTSR:
- Metsera, Inc. Approves 2024 Executive Cash Bonuses
- Metsera initiated with an Outperform at Evercore ISI
- Metsera, Inc.: Buy Rating Affirmed Due to Innovative Obesity Market Approach and Strong Growth Catalysts
- Metsera initiated with a Buy at BofA
- Metsera, Inc.: A Promising Buy in the Obesity Market with Potential for Significant Returns